These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23762301)

  • 61. Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma.
    Sicard H; Al Saati T; Delsol G; Fournié JJ
    Mol Med; 2001 Oct; 7(10):711-22. PubMed ID: 11713370
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro.
    Liu X; Feng T; Gong T; Shen C; Zhu T; Wu Q; Li Q; Li H
    Biomed Res Int; 2015; 2015():317801. PubMed ID: 25984529
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
    Izumi T; Kondo M; Takahashi T; Fujieda N; Kondo A; Tamura N; Murakawa T; Nakajima J; Matsushita H; Kakimi K
    Cytotherapy; 2013 Apr; 15(4):481-91. PubMed ID: 23391461
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.
    Liu F; Hu X; Zimmerman M; Waller JL; Wu P; Hayes-Jordan A; Lev D; Liu K
    PLoS One; 2011 Jan; 6(1):e16241. PubMed ID: 21264227
    [TBL] [Abstract][Full Text] [Related]  

  • 65. V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.
    D'Asaro M; La Mendola C; Di Liberto D; Orlando V; Todaro M; Spina M; Guggino G; Meraviglia S; Caccamo N; Messina A; Salerno A; Di Raimondo F; Vigneri P; Stassi G; Fourniè JJ; Dieli F
    J Immunol; 2010 Mar; 184(6):3260-8. PubMed ID: 20154204
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.
    Benzaïd I; Mönkkönen H; Stresing V; Bonnelye E; Green J; Mönkkönen J; Touraine JL; Clézardin P
    Cancer Res; 2011 Jul; 71(13):4562-72. PubMed ID: 21646473
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Celastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors.
    Li Z; Zhang J; Tang J; Wang R
    Oncotarget; 2016 Dec; 7(51):84388-84397. PubMed ID: 27768597
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells.
    Xiao L; Chen C; Li Z; Zhu S; Tay JC; Zhang X; Zha S; Zeng J; Tan WK; Liu X; Chng WJ; Wang S
    Cytotherapy; 2018 Mar; 20(3):420-435. PubMed ID: 29402645
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.
    De Miguel D; Gallego-Lleyda A; Ayuso JM; Pejenaute-Ochoa D; Jarauta V; Marzo I; Fernández LJ; Ochoa I; Conde B; Anel A; Martinez-Lostao L
    Cancer Lett; 2016 Dec; 383(2):250-260. PubMed ID: 27725224
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sensitization of human osteosarcoma cells to Vγ9Vδ2 T-cell-mediated cytotoxicity by zoledronate.
    Li Z; Peng H; Xu Q; Ye Z
    J Orthop Res; 2012 May; 30(5):824-30. PubMed ID: 22025284
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts.
    Psahoulia FH; Drosopoulos KG; Doubravska L; Andera L; Pintzas A
    Mol Cancer Ther; 2007 Sep; 6(9):2591-9. PubMed ID: 17876056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.
    Wu Y; Deng Z; Wang H; Ma W; Zhou C; Zhang S
    BMC Immunol; 2016 Sep; 17(1):29. PubMed ID: 27645787
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
    Baritaki S; Huerta-Yepez S; Sakai T; Spandidos DA; Bonavida B
    Mol Cancer Ther; 2007 Apr; 6(4):1387-99. PubMed ID: 17431117
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The CD226-ERK1/2-LAMP1 pathway is an important mechanism for Vγ9Vδ2 T cell cytotoxicity against chemotherapy-resistant acute myeloid leukemia blasts and leukemia stem cells.
    Wu K; Wang LM; Liu M; Xiu Y; Hu Y; Fu S; Huang H; Xu B; Xiao H
    Cancer Sci; 2021 Aug; 112(8):3233-3242. PubMed ID: 34107135
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunotherapy targeting colon cancer stem cells.
    Iovino F; Meraviglia S; Spina M; Orlando V; Saladino V; Dieli F; Stassi G; Todaro M
    Immunotherapy; 2011 Jan; 3(1):97-106. PubMed ID: 21174560
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells.
    Liu M; Sun LL; Li YJ; Li HY; Zhang J; Li BH; Ye ZM
    Int Immunopharmacol; 2015 Sep; 28(1):160-7. PubMed ID: 26071219
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
    Ibusuki A; Kawai K; Yoshida S; Uchida Y; Nitahara-Takeuchi A; Kuroki K; Kajikawa M; Ose T; Maenaka K; Kasahara M; Kanekura T
    J Invest Dermatol; 2014 Feb; 134(2):396-404. PubMed ID: 23962808
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
    Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
    Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synergistic antitumor effect of TRAIL and doxorubicin on colon cancer cell line SW480.
    Xu LH; Deng CS; Zhu YQ; Liu SQ; Liu DZ
    World J Gastroenterol; 2003 Jun; 9(6):1241-5. PubMed ID: 12800232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.